Skip to content

Added to your cart:

Cart subtotal

Ibuprofen Lysine for Injection 10 mg/mL Single Use Vial 2 mL x 3 Vials

SKU 66993-0490-36
Sale 24%
Original price $ 2,395.00
Current price $ 1,825.00
In stock
Non-Returnable
*Mountainside Medical does not fill personal prescriptions Medical Professional License Required to Unlock Account

How to Order:

āœ” Send an email request to: sales@mountainside-medical.com

You will receive instructions on how to create an account along with Rx Ordering Details.

(Note: Acceptable licenses must have Prescriptive Authority in the license issuing state.)
Fast Delivery
Fast Delivery
24/7 Support
24/7 Support
No Returns
No Returns
Hospital Grade
Hospital Grade
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Service-Disabled Veteran-Owned Small Business
Service-Disabled Veteran-Owned Small Business
Located in Adirondack Mountains in NY
Located in Adirondack Mountains in NY
Family Owned Business 2002
Family Owned Business 2002
Sale 24%
Original price $ 2,395.00
Current price $ 1,825.00
Free Shipping on orders above $100
Payment Secure transaction
Packaging Ships in product packaging
Ibuprofen Lysine for Injection 10 mg/mL Single Use Vial 2 mL x 3 Vials
Ibuprofen Lysine for Injection 10 mg/mL Single Use Vial 2 mL x 3 Vials
$ 2,395.00 $ 1,825.00
šŸ”’ Medical License Required
Description

Ibuprofen Lysine for Injection 10 mg/mL Single Use Vial 2 mL x 3 Vials. Ibuprofen Lysine is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc.) is ineffective. The clinical trial was conducted among infants with an asymptomatic PDA. However, the consequences beyond 8 weeks after treatment have not been evaluated; therefore, treatment should be reserved for infants with clear evidence of a clinically significant PDA.

Ibuprofen lysine is used to treat patent ductus arteriosus (PDA) in premature infants (babies born too early) who weigh between 1.1 and 3.3 pounds. PDA is a heart problem where a blood vessel, the ductus arteriosus, fails to close normally after birth.

Ā 

Description

Ibuprofen Lysine for Injection 10 mg/mL Single Use Vial 2 mL x 3 Vials. Ibuprofen Lysine is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc.) is ineffective. The clinical trial was conducted among infants with an asymptomatic PDA. However, the consequences beyond 8 weeks after treatment have not been evaluated; therefore, treatment should be reserved for infants with clear evidence of a clinically significant PDA.

Ibuprofen lysine is used to treat patent ductus arteriosus (PDA) in premature infants (babies born too early) who weigh between 1.1 and 3.3 pounds. PDA is a heart problem where a blood vessel, the ductus arteriosus, fails to close normally after birth.

Ā 

Get Notified When Back in Stock